Cover Image
市場調查報告書

Celsus Therapeutics Plc的產品平台分析

Celsus Therapeutics Plc - Product Pipeline Review - 2015

出版商 Global Markets Direct 商品編碼 312699
出版日期 內容資訊 英文 24 Pages
訂單完成後即時交付
價格
Back to Top
Celsus Therapeutics Plc的產品平台分析 Celsus Therapeutics Plc - Product Pipeline Review - 2015
出版日期: 2015年08月26日 內容資訊: 英文 24 Pages
簡介

Celsus Therapeutics Plc是總公司位於英國的製藥企業,集中於皮膚、呼吸系統、眼、腸胃的發炎疾病及骨關節炎、血管新生、心血管、中樞神經系統、癌症等領域,正在開發抗發炎藥。

本報告提供Celsus Therapeutics Plc的治療藥開發平台現狀及各開發階段比較分析,提供您藥物標的,作用機制,給藥途徑,各分子類型的治療藥評估,最新的企業新聞和發表,後期階段及中止的計劃等相關資訊。

目錄

Celsus Therapeutics Plc的基本資料

  • Celsus Therapeutics Plc概要
  • 主要資訊
  • 企業資料

Celsus Therapeutics Plc:R&D概要

  • 主要的治療範圍

Celsus Therapeutics Plc:開發平台評估

  • 各開發階段的開發中產品
  • 單劑產品

Celsus Therapeutics Plc:開發中產品概況

  • 臨床階段的開發中產品
    • 第二階段的產品/聯合治療模式
  • 初期階段產品開發中產品
    • 前臨床階段的產品/聯合治療模式

Celsus Therapeutics Plc:藥物簡介

  • MRX-6
  • CFX-1
  • MRX-5
  • OPX-1

Celsus Therapeutics Plc:開發平台分析

  • 標的別
  • 各給藥途徑
  • 各分子類型
  • 各作用機制

Celsus Therapeutics Plc:最新的開發平台資訊

Celsus Therapeutics Plc:開發暫停中的計劃

Celsus Therapeutics Plc:總公司和子公司的所在地

  • 總公司
  • 分公司及子公司

附錄

圖表一覽

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GMDHC07475CDB

Summary

Global Markets Direct's, 'Celsus Therapeutics Plc - Product Pipeline Review - 2015', provides an overview of the Celsus Therapeutics Plc's pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Celsus Therapeutics Plc's, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of Celsus Therapeutics Plc including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of Celsus Therapeutics Plc's human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the Celsus Therapeutics Plc's pipeline products

Reasons to buy

  • Evaluate Celsus Therapeutics Plc's strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of Celsus Therapeutics Plc in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the Celsus Therapeutics Plc's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of Celsus Therapeutics Plc and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of Celsus Therapeutics Plc
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of Celsus Therapeutics Plc and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Celsus Therapeutics Plc Snapshot
    • Celsus Therapeutics Plc Overview
    • Key Information
    • Key Facts
  • Celsus Therapeutics Plc - Research and Development Overview
    • Key Therapeutic Areas
  • Celsus Therapeutics Plc - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
  • Celsus Therapeutics Plc - Pipeline Products Glance
    • Celsus Therapeutics Plc - Early Stage Pipeline Products
      • Preclinical Products/Combination Treatment Modalities
  • Celsus Therapeutics Plc - Drug Profiles
    • CFX-1
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • MRX-5
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • OAX-1
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • OPX-1
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • Celsus Therapeutics Plc - Pipeline Analysis
    • Celsus Therapeutics Plc - Pipeline Products by Target
    • Celsus Therapeutics Plc - Pipeline Products by Route of Administration
    • Celsus Therapeutics Plc - Pipeline Products by Molecule Type
    • Celsus Therapeutics Plc - Pipeline Products by Mechanism of Action
  • Celsus Therapeutics Plc - Recent Pipeline Updates
  • Celsus Therapeutics Plc - Dormant Projects
  • Celsus Therapeutics Plc - Locations And Subsidiaries
    • Head Office
    • Other Locations & Subsidiaries
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • Celsus Therapeutics Plc, Key Information
  • Celsus Therapeutics Plc, Key Facts
  • Celsus Therapeutics Plc - Pipeline by Indication, 2015
  • Celsus Therapeutics Plc - Pipeline by Stage of Development, 2015
  • Celsus Therapeutics Plc - Monotherapy Products in Pipeline, 2015
  • Celsus Therapeutics Plc - Preclinical, 2015
  • Celsus Therapeutics Plc - Pipeline by Target, 2015
  • Celsus Therapeutics Plc - Pipeline by Route of Administration, 2015
  • Celsus Therapeutics Plc - Pipeline by Molecule Type, 2015
  • Celsus Therapeutics Plc - Pipeline Products by Mechanism of Action, 2015
  • Celsus Therapeutics Plc - Recent Pipeline Updates, 2015
  • Celsus Therapeutics Plc - Dormant Developmental Projects,2015
  • Celsus Therapeutics Plc, Other Locations
  • Celsus Therapeutics Plc, Subsidiaries

List of Figures

  • Celsus Therapeutics Plc - Pipeline by Top 10 Indication, 2015
  • Celsus Therapeutics Plc - Pipeline by Top 10 Target, 2015
  • Celsus Therapeutics Plc - Pipeline by Top 10 Route of Administration, 2015
  • Celsus Therapeutics Plc - Pipeline Products by Top 10 Mechanism of Action, 2015
Back to Top